Maria R. Sazatornil-Abad

Zaragoza, AR 50009, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

External validation of population pharmacokinetic models of adalimumab in adult patients with inflammatory bowel disease: towards model-informed precision dosing.

External validation of population pharmacokinetic models of adalimumab in adult patients with inflammatory bowel disease: towards model-informed precision dosing.

Journal: Journal of pharmacokinetics and pharmacodynamics
Published: January 22, 2026

LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation.

LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation.

Journal: PloS one
Published: December 02, 2025

Safety of Bruton kinase inhibitors in chronic lymphocytic leukemia: Real world clinical practice.

Safety of Bruton kinase inhibitors in chronic lymphocytic leukemia: Real world clinical practice.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: September 24, 2025

[Translated article] Safety of Bruton kinase inhibitors in chronic lymphocytic leukemia: Real world clinical practice.

[Translated article] Safety of Bruton kinase inhibitors in chronic lymphocytic leukemia: Real world clinical practice.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: September 24, 2025

[Translated article] OrPhar-SEFH 2024-2027 Strategic Plan.

[Translated article] OrPhar-SEFH 2024-2027 Strategic Plan.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: December 23, 2024

Pharmaceutical care for the patients admitted to a multidisciplinary complex chronic patient unit.

Pharmaceutical care for the patients admitted to a multidisciplinary complex chronic patient unit.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: June 28, 2022

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Journal: Epilepsy & behavior : E&B
Published: February 01, 2022

Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study.

Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study.

Journal: BMC health services research
Published: July 17, 2020

Safety assessment of new oral anticoagulants.

Safety assessment of new oral anticoagulants.

Journal: Medicina clinica
Published: October 02, 2018

Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.

Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.

Journal: International journal of clinical pharmacy
Published: August 28, 2017

Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer.

Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer.

Journal: International journal of clinical pharmacy
Published: July 30, 2015

Clinical significance of the sodium content of intravenous antibiotic therapy

Clinical significance of the sodium content of intravenous antibiotic therapy

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: March 28, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026